- ￥10706
- OriGene
- BM4025B
- 美国
- 2026年04月01日
- ELISA, IHC
- Mouse
- Human
企业认证
相关产品推荐更多 >
Carrier-free (BSA/glycerol-free) CHN1 mouse monoclonal antibody, clone OTI2G6 (formerly 2G6)
￥3999Mouse Monoclonal AcGFP1/PS-CFP2 Antibody, Magnetic Beads
￥6260Carrier-free (BSA/glycerol-free) PSMD9 mouse monoclonal antibody,clone OTI5H2
￥3999Carrier-free (BSA/glycerol-free) ARFGAP1 mouse monoclonal antibody, clone OTI1F6 (formerly 1F6)
￥3999
GRIA1 rabbit polyclonal antibody, Serum
￥6600
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
阿拉丁试剂，充足现货，稳定批间差Cytoscape 教程来了！快速实现顶刊同款通路网络图五大应用案例：Mustang Q 膜层析应用全解析1 个小工具，一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 抗体名：
MRP8/14 (S100A8/A9) mouse monoclonal antibody, clone 27E10, Biotin
- 抗体英文名：
MRP8/14 (S100A8/A9) mouse monoclonal antibody, clone 27E10, Biotin
- 应用范围：
ELISA, IHC
- 宿主：
Mouse
- 适应物种：
Human
- 保质期：
Stable for 12 months from date of receipt.
- 目录编号：
BM4025B
- 级别：
科研级
- 库存：
5周
- 供应商：
OriGene
- 克隆性：
Monoclonal
- 保存条件：
Store lyophilized at 2-8°C for 6 months or at -20°C long term.After reconstitution store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C long term. Do not freeze working dilutionsAvoid repeated freezing and thawing.
- 形态：
PBS, pH 7.2Label: BiotinState: Lyophilized purified IgG fractionStabilizer: 5 mg/ml BSAPreservative: 0.05% (v/v) Kathon CG
- 免疫原：
Cultured Human monocytes.
- 规格：
100 ug
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Monoclonal Antibody Production
and screening of the hybridomas: 1. Bleeding Mice (1) Place the mouse in a mouse restrainer. (2) Sterilize the tail with 70% ethanol. (3) With a razor blade,nip off the last 2 mm of the tip of the tail. (4) Using a milking motion,pull blood down and let
Monoclonal Antibody Production
Monoclonal Antibody Production Mouse Immunization Order 6 six week old Balb/C mice and let the ARC know they are coming. Have your antigen ready for when they arrive. Once they get there earmark the mice and perform
【翻译】Development trends for monoclonal antibody cancer therapeutics
). However, since 2000, humanized and human mAbs have been entering clinical study at approximately the same rate (4.3 versus 4.5 mAbs per year, respectively). Figure 1 | Categories of monoclonal antibody cancer therapeutics entering clinical study during 1980–1989
技术资料暂无技术资料 索取技术资料
